Skip to content

Drug interactions

Ethosuximide + Pirtobrutinib

Severity: Minor

Ethosuximide and Pirtobrutinib: minor interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Pirtobrutinib weakly inhibits CYP3A4 and may raise exposure to CYP3A4 substrates. Ethosuximide levels may increase modestly, with greater risk of adverse effects.

What this interaction means in plain words

Ethosuximide and Pirtobrutinib have a small, usually unimportant interaction. Most people can take both; the pharmacist may still mention it so that any unexpected effect is recognised.

Ethosuximide belongs to Central Nervous System; Pirtobrutinib belongs to Oncology.

Evidence level: Low

Why it happens

CYP3A4 inhibition by pirtobrutinib reducing ethosuximide clearance.

What to do

Monitor for ethosuximide adverse effects such as drowsiness and nausea, and reduce the dose if they occur.

What to ask your pharmacist

  • Is there anything I should notice while taking both?
  • Do I need to tell my doctor at the next visit?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Ethosuximide and Pirtobrutinib, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 7 days on the web. No card needed.

Frequently asked questions

Can I take Ethosuximide with Pirtobrutinib?

MediHelp rates the interaction as minor. Ethosuximide and Pirtobrutinib have a small, usually unimportant interaction. Most people can take both; the pharmacist may still mention it so that any unexpected effect is recognised. Pirtobrutinib weakly inhibits CYP3A4 and may raise exposure to CYP3A4 substrates. Ethosuximide levels may increase modestly, with greater risk of adverse effects.

How serious is the interaction between Ethosuximide and Pirtobrutinib?

MediHelp rates it minor, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Monitor for ethosuximide adverse effects such as drowsiness and nausea, and reduce the dose if they occur.

What other medicines interact with Ethosuximide?

MediHelp also lists interactions of Ethosuximide with, for example, Benzhydrocodone / acetaminophen, Buprenorphine long-acting, Buprenorphine subdermal implant. The full list is on the Ethosuximide page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in